Paul J. Clancy
2013
In 2013, Paul J. Clancy earned a total compensation of $4.5M as EVP, Chief Financial Officer at Biogen, a 22% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $27,771 |
|---|---|
| Non-Equity Incentive Plan | $683,258 |
| Salary | $745,223 |
| Stock Awards | $2,808,961 |
| Other | $221,043 |
| Total | $4,486,256 |
Clancy received $2.8M in stock awards, accounting for 63% of the total pay in 2013.
Clancy also received $27.8K of change in pension value and nonqualified deferred compensation earnings, $683.3K in non-equity incentive plan, $745.2K in salary and $221K in other compensation.
Rankings
In 2013, Paul J. Clancy's compensation ranked 1,478th out of 12,286 executives tracked by ExecPay. In other words, Clancy earned more than 88.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,478 out of 12,286 | 88th |
Division Manufacturing | 477 out of 4,614 | 90th |
Major group Chemicals And Allied Products | 128 out of 1,466 | 91st |
Industry group Drugs | 86 out of 1,160 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 9 out of 200 | 96th |
Source: SEC filing on April 15, 2016.
Clancy's colleagues
We found five more compensation records of executives who worked with Paul J. Clancy at Biogen in 2013.
2013
George Scangos
Biogen
Chief Executive Officer
2013
Douglas Williams
Biogen
Former EVP, Research and Development
2013
Raymond Pawlicki
Biogen
Former SVP, Chief Information Officer
2013
Stuart Kingsley
Biogen
Former EVP, Global Operations
2013
John Cox
Biogen